(MedPage Today) -- A drug widely used for a rare neurological condition that mainly affects overweight women -- pseudotumor cerebri -- has successfully passed its first randomized trial, researchers reported. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment